Mutations in PIK3CA, which encodes the p110a subunit of PI3K, occur in approximately 20% of GCs [20], however PIK3CA mutations are less frequent in HER2-positive GC, occurring in only 2% of tumours [21]. Here, ERBB2 is linked to neoplasm.